Marshall Fordyce Vera Therapeutics, Inc. (VERA) insider trading activity

VERA Quotes by TradingView

Marshall Fordyce is PRESIDENT AND CEO of Vera Therapeutics, Inc.. Currently has a direct ownership of 85,942 shares of VERA, which is worth approximately $4.06 Million. The most recent transaction as insider was on Sep 12, 2022, when has been sold 16,136 shares (Class A Common Stock) at a price of $20.8 per share, resulting in proceeds of $335,629. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 85.9K
73.37% 3M change
64.69% 12M change
Total Value Held $4.06 Million

Marshall Fordyce Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 12 2022
SELL
Open market or private sale
$335,629 $20.8 p/Share
16,136 Reduced 8.18%
181,150 Class A Common Stock
Sep 12 2022
BUY
Exercise of conversion of derivative security
$46,794 $2.9 p/Share
16,136 Added 8.04%
184,465 Class A Common Stock
Sep 09 2022
SELL
Open market or private sale
$259,782 $20.16 p/Share
12,886 Reduced 6.64%
181,150 Class A Common Stock
Sep 09 2022
BUY
Exercise of conversion of derivative security
$37,369 $2.9 p/Share
12,886 Added 6.23%
194,036 Class A Common Stock
Sep 08 2022
SELL
Open market or private sale
$309,975 $20.52 p/Share
15,106 Reduced 7.7%
181,150 Class A Common Stock
Sep 08 2022
BUY
Exercise of conversion of derivative security
$43,807 $2.9 p/Share
15,106 Added 7.15%
196,256 Class A Common Stock
Sep 07 2022
SELL
Open market or private sale
$135,904 $20.03 p/Share
6,785 Reduced 3.61%
181,150 Class A Common Stock
Sep 07 2022
BUY
Exercise of conversion of derivative security
$19,677 $2.9 p/Share
6,785 Added 3.48%
187,935 Class A Common Stock
Sep 02 2022
SELL
Open market or private sale
$356,964 $20.88 p/Share
17,096 Reduced 8.62%
181,150 Class A Common Stock
Sep 02 2022
BUY
Exercise of conversion of derivative security
$49,578 $2.9 p/Share
17,096 Added 8.22%
190,900 Class A Common Stock
Sep 01 2022
SELL
Open market or private sale
$362,862 $21.22 p/Share
17,100 Reduced 8.63%
181,150 Class A Common Stock
Sep 01 2022
BUY
Exercise of conversion of derivative security
$49,590 $2.9 p/Share
17,100 Added 7.94%
198,250 Class A Common Stock
Aug 19 2022
BUY
Grant, award, or other acquisition
-
43,750 Added 19.45%
181,150 Class A Common Stock
Aug 12 2022
SELL
Open market or private sale
$413,844 $20.16 p/Share
20,528 Reduced 13.0%
137,400 Class A Common Stock
Aug 12 2022
BUY
Exercise of conversion of derivative security
$59,531 $2.9 p/Share
20,528 Added 11.5%
157,928 Class A Common Stock
MF

Marshall Fordyce

PRESIDENT AND CEO
Brisbane, CA

Track Institutional and Insider Activities on VERA

Follow Vera Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VERA shares.

Notify only if

Insider Trading

Get notified when an Vera Therapeutics, Inc. insider buys or sells VERA shares.

Notify only if

News

Receive news related to Vera Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VERA